EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potentiating the Cross-Reactive IFN-γ T Cell and Polyfunctional T Cell Responses by Heterologous GX-19N DNA Booster in Mice Primed with Either a COVID-19 mRNA Vaccine or Inactivated Vaccine

Yong Bok Seo, Ara Ko, Duckhyang Shin, Junyoung Kim, You Suk Suh, Juyoung Na, Ji In Ryu, Suyeon Lee, Min Ji Oh, Young Chul Sung

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yong Bok Seo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Waning vaccine-induced immunity, coupled with the emergence of SARS-CoV-2 variants, has inspired the widespread implementation of COVID-19 booster vaccinations. Here, we evaluated the potential of the GX-19N DNA vaccine as a heterologous booster to enhance the protective immune response to SARS-CoV-2 in mice primed with either an inactivated virus particle (VP) or an mRNA vaccine. We found that in the VP-primed condition, GX-19N enhanced the response of both vaccine-specific antibodies and cross-reactive T Cells to the SARS-CoV-2 variant of concern (VOC), compared to the homologous VP vaccine prime-boost. Under the mRNA-primed condition, GX-19N induced higher vaccine-induced T Cell responses but lower antibody responses than the homologous mRNA vaccine prime-boost. Furthermore, the heterologous GX-19N boost induced higher S-specific polyfunctional CD4+ and CD8+ T cell responses than the homologous VP or mRNA prime-boost vaccinations. Our results provide new insights into booster vaccination strategies for the management of novel COVID-19 variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesT-LymphocytesAnimalsHumansMiceAntibodies, NeutralizingAntibodies, ViralDNARNA, MessengerSARS-CoV-2VaccinationVaccines, InactivatedInterferon-gammamRNA VaccinesVaccines, DNA

Stichwörter der Autor:innen

COVID-19DNA vaccineSARS-CoV-2mRNA vaccine

Substanzen

Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesDNARNA, MessengerVaccines, InactivatedInterferon-gammamRNA VaccinesGX-19N vaccineVaccines, DNA

Autor:innen und Institutionen

  • Research Institute, SL VaxiGen Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
  • Research Institute, Genexine Inc., Korea Bio Park, Seongnam 13488, Republic of Korea.
  • Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.

Zitieren

APA

Seo, Y. B., Ko, A., Shin, D., Kim, J., Suh, Y. S., Na, J., Ryu, J. I., Lee, S., Oh, M. J., & Sung, Y. C. (2023). Potentiating the Cross-Reactive IFN-γ T Cell and Polyfunctional T Cell Responses by Heterologous GX-19N DNA Booster in Mice Primed with Either a COVID-19 mRNA Vaccine or Inactivated Vaccine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119753

Vancouver

Seo YB, Ko A, Shin D, Kim J, Suh YS, Na J, et al. Potentiating the Cross-Reactive IFN-γ T Cell and Polyfunctional T Cell Responses by Heterologous GX-19N DNA Booster in Mice Primed with Either a COVID-19 mRNA Vaccine or Inactivated Vaccine. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119753

BibTeX
@article{Seo2023,
  author = {Seo, Yong Bok and Ko, Ara and Shin, Duckhyang and Kim, Junyoung and Suh, You Suk and Na, Juyoung and Ryu, Ji In and Lee, Suyeon and Oh, Min Ji and Sung, Young Chul},
  title = {Potentiating the Cross-Reactive IFN-γ T Cell and Polyfunctional T Cell Responses by Heterologous GX-19N DNA Booster in Mice Primed with Either a COVID-19 mRNA Vaccine or Inactivated Vaccine},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119753}
}
Kostenlos starten →